We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Tekmira Provides Update on TKM-Ebola Phase I Clinical Hold

News   Jul 24, 2014

 
Tekmira Provides Update on TKM-Ebola Phase I Clinical Hold
 
 
 

RELATED ARTICLES

Triple-negative Breast Cancer Influenced by Dual Action of Genes and RNA

News

Women with triple-negative breast cancer could be differentiated from a more common form of the disease by a panel of 17 small RNA molecules.

READ MORE

Even Short-term Vaping Causes Inflammation in Non-smokers, Says Pilot Study

News

Researchers report the first evidence of biological changes correlated with e-cigarette use in never-smokers.

READ MORE

Further Calls for Diversity in Genomics Research

News

Broadening diversity among participants in human genomics research will maximize the potential of the field, say members of an international genomics consortium.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE